Lazertinib,Amivantamab,Carboplatin,Pemetrexed,osimertinib
Yuhan Corp,Janssen,Genmab,AstraZeneca
['chrysalis,(-chrysalis2),(-chrysalis-2),(-chrysalis 2)']
#asco23 #chrysalis n=108, med f/u 10.2 mo 101 evaluate orr 30%, mdor 10.8 months mpfs 5.7 months orr 61% vs 14% in met ihc+/- 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl